Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role.
作者信息
Magro Giuseppe
机构信息
Department of Medical and Surgical Sciences, University "Magna Græcia" of Catanzaro, Italy.
出版信息
Med Hypotheses. 2020 Sep;142:109829. doi: 10.1016/j.mehy.2020.109829. Epub 2020 May 12.
Abstract
摘要
相似文献
1
Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role.细胞因子风暴：它是新冠病毒肺炎患者唯一的主要死亡因素吗？凝血作用。
Med Hypotheses. 2020 Sep;142:109829. doi: 10.1016/j.mehy.2020.109829. Epub 2020 May 12.
2
Focus on coronavirus disease 2019 associated coagulopathy.关注2019冠状病毒病相关凝血病。
Chin Med J (Engl). 2020 Sep 20;133(18):2239-2241. doi: 10.1097/CM9.0000000000001019.
3
COVID-19 and Hypercoagulability.新型冠状病毒肺炎与高凝状态
Clin Adv Hematol Oncol. 2020 Jul;18(7):386-389.
4
[Coagulopathy and COVID-19. Recommendations for a changing reality].[凝血功能障碍与2019冠状病毒病。应对不断变化的现实的建议]
Medicina (B Aires). 2020;80(5):505-511.
5
COVID-19 coagulopathy: an evolving story.新冠病毒感染相关凝血功能障碍：一个不断演变的故事。
Lancet Haematol. 2020 Jun;7(6):e425. doi: 10.1016/S2352-3026(20)30151-4.
6
COVID-19 and SIC (!).2019冠状病毒病与噬血细胞性淋巴组织细胞增生症（！）
J Vasc Surg. 2020 Sep;72(3):1148-1150. doi: 10.1016/j.jvs.2020.05.047. Epub 2020 Jun 1.
7
Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients.新冠病毒感染患者的凝血病与抗凝治疗的可能获益。
Curr Probl Cardiol. 2020 Sep;45(9):100648. doi: 10.1016/j.cpcardiol.2020.100648. Epub 2020 Jun 27.
8
Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
9
Coagulopathy in COVID-19: Focus on vascular thrombotic events.新型冠状病毒肺炎相关凝血功能障碍：关注血管血栓栓塞事件。
J Mol Cell Cardiol. 2020 Sep;146:32-40. doi: 10.1016/j.yjmcc.2020.07.003. Epub 2020 Jul 15.
10
COVID-19 coagulopathy vs disseminated intravascular coagulation.新型冠状病毒肺炎凝血病与弥散性血管内凝血
Blood Adv. 2020 Jun 23;4(12):2850. doi: 10.1182/bloodadvances.2020002197.
引用本文的文献
1
The complement system in preeclampsia: a review of its activation and endothelial injury in the triad of COVID-19 infection and HIV-associated preeclampsia.子痫前期中的补体系统：COVID-19感染与HIV相关子痫前期三联征中补体系统的激活及其对内皮损伤的综述
Obstet Gynecol Sci. 2023 Jul;66(4):253-269. doi: 10.5468/ogs.22175. Epub 2023 Jan 4.
2
SILAC-based chemoproteomics reveals a neoligan analogue as an anti-inflammatory agent targeting IRGM to ameliorate cytokine storm.基于 SILAC 的化学生物组学揭示了一种新的脂联素类似物作为一种抗炎剂，通过靶向 IRGM 来改善细胞因子风暴。
Eur J Med Chem. 2022 Nov 5;241:114659. doi: 10.1016/j.ejmech.2022.114659. Epub 2022 Aug 8.
3
Arterial and venous thromboembolism in critically ill, COVID 19 positive patients admitted to Intensive Care Unit.入住重症监护病房的新冠肺炎阳性重症患者的动脉和静脉血栓栓塞
Ann Vasc Surg. 2022 Mar 4. doi: 10.1016/j.avsg.2022.02.005.
4
Physiological Role and Use of Thyroid Hormone Metabolites - Potential Utility in COVID-19 Patients.甲状腺激素代谢产物的生理作用及应用 - COVID-19 患者的潜在用途。
Front Endocrinol (Lausanne). 2021 Apr 26;12:587518. doi: 10.3389/fendo.2021.587518. eCollection 2021.
5
Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications.减轻新型冠状病毒肺炎（SARS-CoV-2）感染诱导的细胞因子风暴的影响及其意义
J Inflamm Res. 2021 Apr 16;14:1487-1510. doi: 10.2147/JIR.S301784. eCollection 2021.
6
Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China.前瞻性研究：中国中医药治疗新冠肺炎患者的进展
Front Pharmacol. 2021 Feb 25;11:615287. doi: 10.3389/fphar.2020.615287. eCollection 2020.
本文引用的文献
1
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.新型冠状病毒肺炎患者的凝血障碍与抗磷脂抗体
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
2
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
3
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
4
Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: A Prospective Pilot Study.急性呼吸窘迫综合征中凝血与纤溶的激活：一项前瞻性初步研究。
Front Med (Lausanne). 2016 Nov 28;3:64. doi: 10.3389/fmed.2016.00064. eCollection 2016.
5
The anti-inflammatory effects of heparin and related compounds.肝素及相关化合物的抗炎作用。
Thromb Res. 2008;122(6):743-52. doi: 10.1016/j.thromres.2006.10.026. Epub 2007 Aug 28.
6
Coronaviridae and SARS-associated coronavirus strain HSR1.冠状病毒科与严重急性呼吸综合征相关冠状病毒株HSR1
Emerg Infect Dis. 2004 Mar;10(3):413-8. doi: 10.3201/eid1003.030683.
7
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry.疱疹病毒与硫酸乙酰肝素：助力病毒进入的密切关系。
J Clin Invest. 2001 Aug;108(4):503-10. doi: 10.1172/JCI13799.
Zotero 插件